Lista de obras - Cristiana Bergamini - Dominio Público Uruguay

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.

artículo científico publicado en 2016

A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer

artículo científico publicado en 2020

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

artículo científico publicado en 2019

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

artículo científico publicado en 2017

Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development

scientific article published on 30 November 2020

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

scientific article published on 20 March 2019

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

artículo científico publicado en 2008

Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.

artículo científico publicado en 2017

Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.

artículo científico publicado en 2015

Comment on “Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis”, by Rades et coll

article

Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.

artículo científico publicado en 2013

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer

artículo científico publicado en 2011

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

artículo científico publicado en 2016

Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.

artículo científico publicado en 2007

Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer

artículo científico publicado en 2014

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.

artículo científico publicado en 2016

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

scientific article published on 04 April 2019

Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy

artículo científico publicado en 2015

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

artículo científico publicado en 2006

Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI).

artículo científico publicado en 2019

Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.

artículo científico publicado en 2018

Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas?

Is Restoring Platinum Sensitivity the Best Goal for Cetuximab in Recurrent/Metastatic Nasopharyngeal Cancer?

artículo científico publicado en 2005

Lenvatinib-induced renal failure: two first-time case reports and review of literature.

artículo científico publicado en 2018

Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series

artículo científico publicado en 2020

Management of loco-regionally advanced squamous laryngeal cancer in elderly patients

artículo científico publicado en 2020

Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients

scientific article published on 11 October 2018

New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors.

artículo científico publicado en 2015

Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.

artículo científico publicado en 2017

PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents

artículo científico publicado en 2019

Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life

artículo científico publicado en 2020

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract

scientific article published on 29 July 2019

Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review

artículo científico publicado en 2014

Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study

artículo científico publicado en 2017

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

article

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2019

Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands

artículo científico publicado en 2020

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.

artículo científico publicado en 2018

RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?

artículo científico publicado en 2017

Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience

artículo científico publicado en 2017

Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case report

artículo científico publicado en 2016

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy

artículo científico publicado en 2016

Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up

scientific article published on 09 July 2019

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

artículo científico publicado en 2017

Targeted therapy in head and neck cancer.

artículo científico publicado en 2011

Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.

artículo científico publicado en 2016

The dilemma of metastatic medullary thyroid carcinoma: when to start systemic treatment

artículo científico publicado en 2019

Treatment of HER2+ metastatic salivary ductal carcinoma in a pregnant woman: a case report

artículo científico publicado en 2019

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).

artículo científico publicado en 2009

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.

artículo científico publicado en 2011

Lista de obras de Cristiana Bergamini

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.

A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.

Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.

Comment on “Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis”, by Rades et coll

Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.

Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI).

Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.

Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas?

Is Restoring Platinum Sensitivity the Best Goal for Cetuximab in Recurrent/Metastatic Nasopharyngeal Cancer?

Lenvatinib-induced renal failure: two first-time case reports and review of literature.

Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series

Management of loco-regionally advanced squamous laryngeal cancer in elderly patients

Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients

New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors.

Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.

PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents

Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract

Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review

Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.

RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?

Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience

Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case report

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy

Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

Targeted therapy in head and neck cancer.

Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.

The dilemma of metastatic medullary thyroid carcinoma: when to start systemic treatment

Treatment of HER2+ metastatic salivary ductal carcinoma in a pregnant woman: a case report

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.